ArticleResearch square2025

Circadian variation in MGMT promoter methylation and expression predicts sensitivity to Temozolomide in glioblastoma.

Maria F Gonzalez-Aponte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.